Advertisement

Epinephrine Injection

[08 October 2014]

Products Affected - Description

Epinephrine injection, American Regent
1 mg/mL, 1 mL ampule, sulfite-free, package of 25 (NDC 00517-1071-25)
1 mg/mL, 30 mL multi-dose vial, package of 5 (NDC 00517-1130-05)
 
Epinephrine injection, Amphastar
1 mg/mL, 30 mL vial (NDC 76329-9061-00)

Reason for the Shortage

  • American Regent has epinephrine on shortage due to manufacturing delays.
  • Hospira had epinephrine syringes on shortage due to manufacturing delays.
  • Amphastar states the shortage is due to increased demand.

Available Products

Epinephrine injection, Amphastar
0.1 mg/mL 10 mL syringe, package of 10 (NDC 76329-3316-01)

Epinephrine injection, Hospira
0.1 mg/mL, 10 mL Lifeshield 18 gauge glass syringe, package of 10 (NDC 00409-4901-18)
0.1 mg/mL, 10 mL Lifeshield 21 gauge glass syringe, package of 10 (NDC 00409-4921-34)
1 mg/mL, 1 mL ampule, preservative-free (contains sulfite), package of 25, (NDC 00409-7241-01)

Adrenalin injection, Par (formerly JHP products)
1 mg/mL, 1 mL vial, preservative-free (contains sulfite), package of 25, (NDC 42023-0159-25)

Estimated Resupply Dates

  • American Regent has epinephrine 1 mg/mL 30 mL vials and epinephrine 1 mg/mL preservative free (sulfite-free) 1 mL ampules on back order and the company cannot estimate a release date.
  • Amphastar has limited supplies of epinephrine 1 mg/mL 30 mL vials and is releasing product regularly.

Related Shortages

Updated

October 8, 2014; August 26, 2014; August 6, 2014; June 11, 2014; April 30, 2014; April 3, 2014; March 7, 2014; February 19, 2014; January 16, 2014; December 13, 2013; October 16, 2013; October 15, 2013; September 16, 2013; August 13, 2013; July 1, 2013; June 19, 2013; May 30, 2013; May 9, 2013; April 26, 2013; March 21, 2013; February 25, 2013; January 14, 2013; December 26, 2012; December 18, 2012; December 3, 2012; November 30, 2012; November 7, 2012; October 26, 2012; September 25, 2012; August 17, 2012; August 1, 2012; July 25, 2012; June 28, 2012; June 15, 2012; May 18, 2012; March 27, 2012; March 9, 2012; February 23, 2012; February 8, 2012; January 25, 2012; January 17, 2012; January 13, 2012; November 15, 2011; September 14, 2011; August 9, 2011; July 15, 2011; July 15, 2011; June 13; 2011; May 4, 2011; May 3, 2011; University of Utah, Drug Information Service. Copyright 2014, University of Utah, Drug Information Service.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement